TGFBR1, Unactive (T07-35G)
|
|
|
Catalog Number |
Pack Size |
Price (USD) |
|
|
| TGFBR1, Unactive |
T07-35G-20 |
20 ug |
$195 40% OFF |
|
Add to Cart |
| TGFBR1, Unactive |
T07-35G-50 |
50 ug |
$395 40% OFF |
|
Add to Cart |
| TGFBR1, Unactive |
T07-35G-BULK |
BULK |
CONTACT US |
|
|
|
|
* Prices listed in the "shopping cart" are not discount inclusive. Promotional Prices will be applied internally during the processing of orders and net totals adjusted accordingly.
Description: Recombinant human TGFBR1 (80-end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
| Tag: |
GST tag |
| Expression System: |
Sf9 insect cells using baculovirus |
| Species: |
Human |
| Sequence: |
80-end |
| Genbank Number: |
BC071181
|
| |
|
Storage, Stability, and Shipping: Store product at –70
oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Applications: Kinase Assay, Western Blot
Molecular Weight: ~65 kDa
Gene Aliases : AAT5, ALK5, SKR4, ALK-5, TGFR-1, ACVRLK4
Scientific Background: TGFβR1 is a transmembrane serine/threonine protein kinase and a member of the TGFβ receptor subfamily (1). TGFβ regulates cell cycle progression by a unique signaling mechanism that involves its binding to TGFβR2 and activation of TGFβR1. TGFβR1 may be inactivated in many of the cases of human tumor cells refractory to TGFβ-mediated cell cycle arrest. Heterozygous mutations in TGFβR1 and TGFβR2 have been reported in Loeys-Dietz aortic aneurysm syndrome (LDS) and also dominant TGFβR2 mutations have been identified in Marfan syndrome type 2 (MFS2) and familial thoracic aortic aneurysms and dissections (TAAD). Mutations of TGFβR1 and TGFβR2 are associated with atherosclerosis and several human cancers (2).
References:
1. Mátyás, G. et al: Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat. 2006;27(8):760-9.
,br>2. Suarez, B.K. et al: TGFBR1*6A is not associated with prostate cancer in men of European ancestry. Prostate Cancer Prostatic Dis. ,2005;8(1):50-3.
 |
|
Purity: Sample Purity Data. For specific information on a given lot, see related technical data sheet. |
TGFBR1, Unactive Research Areas
The TGFBR1, Unactive product can be utilized in the following research areas, but not limited to:
AKT/PKB Pathway, Angiogenesis, Cancer, Cell Cycle, Cellular Stress, ERK/MAPK Pathway, Inflammation, JAK/STAT Pathway, JNK/SAPK Pathway, NfkB Pathway, Ser/Thr Kinases, WNT Signaling
| Product Type |
Product Name |
Catalog Number |
Application |
Pack Sizes |
| Enzymes |
ALK1, Active |
A09-11G |
Kinase Assay, Western Blot |
View ALK1, Active
|
| Enzymes |
ALK2, Active |
A06-11G |
Kinase Assay, Western Blot |
View ALK2, Active
|
| Enzymes |
ALK4, Active |
A07-11G |
Kinase Assay, Western Blot |
View ALK4, Active
|
| Enzymes |
TGFBR2, Active |
T08-11G |
Kinase Assay, Western Blot |
View TGFBR2, Active
|
| Signaling Reagents |
TGFBR1 Peptide |
T36-58 |
Peptide Substrate |
View TGFBR1 Peptide
|
| Enzymes |
TGFBR1 (ALK5), Active |
T07-11G |
Kinase Assay, Western Blot |
View TGFBR1 (ALK5), Active
|
| Enzymes |
ALK6 (BMPR1B), Active |
B05-11G |
Kinase Assay, Western Blot |
View ALK6 (BMPR1B), Active
|
| Extracellular Ligands |
TGFB3 |
T833-40CN |
Cell Assay |
View TGFB3
|
| Signaling Proteins |
ALK7 Protein |
A08-35G |
Western Blot |
View ALK7 Protein
|
| Extracellular Ligands |
TGFB1 |
T831-40N |
Cell Assay |
View TGFB1
|